Uterine NK cells: active regulators at the maternal-fetal interface

Area of Science:

• Immunology
• Reproductive Biology
• Maternal-Fetal Medicine

Background:

• Pregnancy involves the coexistence of two genetically distinct individuals.
• Maternal lymphocytes, including T cells and uterine NK (uNK) cells, are present at the maternal-fetal interface.
• While T cell responses are tightly regulated, uNK cell activation appears physiological, though their precise role remains unclear.

Purpose of the Study:

• To explore the function of uNK cells in normal and pathological pregnancies.
• To investigate the role of maternal-fetal immune interactions in placentation.
• To understand the implications of NK cell receptor and MHC ligand variability on pregnancy outcomes.

Main Methods:

• Analysis of maternal immune cells at the uterine maternal-fetal interface.
• Genetic epidemiological studies examining NK cell receptors and MHC ligands.
• Investigating allorecognition mechanisms between uNK cells and fetal placental cells.

Main Results:

• Genetic data suggest NK cell receptor and MHC ligand variability are critical for pregnancy success.
• Allorecognition of fetal placental cells by uNK cells is emerging as a central mechanism regulating placentation.
• The exact function of uNK cells in various pregnancy conditions requires further elucidation.

Conclusions:

• Uterine NK cells are likely crucial for successful pregnancy and placentation.
• Therapeutic strategies targeting NK cells require careful consideration due to their complex role.
• Understanding maternal-fetal immune interactions, particularly involving uNK cells, is key to managing pregnancy.